Picard Medical Cash Flow Statement Analysis

Operating, investing, and financing activities in millions USD

Scroll to see more
Cash flow statement showing operating, investing, and financing activities for Picard Medical, Inc. (PMI) - Annual data in millions USD
BreakdownFY 2024FY 2023FY 2022
Period EndingDec 2024Dec 2023Dec 2022
Operating Activities
Net Income-21.06-15.57-11.17
Depreciation & Amortization0.540.590.55
Stock Based Compensation0.890.130.15
Change in Working Capital0.963.28-1.93
Change in Accounts Receivable0.120.250.21
Change in Inventory-1.33-0.45-1.59
Change in Accounts Payable2.211.610.11
Change in Other Working Capital-0.031.87-0.65
Other Operating Activities4.400.881.68
Net Cash from Operating Activities-11.87-10.63-10.72
Investing Activities
Capital Expenditures0.00-0.01-0.03
Other Investing Activities0.000.00-0.01
Net Cash from Investing Activities0.00-0.01-0.04
Financing Activities
Debt Repayment-1.38-0.89-0.03
Net Cash from Financing Activities11.7410.845.52
Summary
Effect of Forex Changes on Cash-0.02-0.110.13
Net Change in Cash-0.150.09-5.24
Cash at Beginning of Period0.240.155.25
Cash at End of Period0.100.240.15
Free Cash Flow-11.87-10.64-10.75
Supplemental Disclosures
Interest Paid0.000.000.00
Income Taxes Paid0.000.000.00